Literature DB >> 7287731

2',5'-Oligo(A)-activated endoribonuclease. Tissue distribution and characterization with a binding assay.

T W Nilsen, D L Wood, C Baglioni.   

Abstract

We have measured the binding of highly radioactive (2'-5')pppA4-5[32P]cytidine 3',5'-diphosphate to human, mouse, and rabbit cell and tissue extracts. A binding activity for this oligonucleotide is present in all extracts examined and high levels of this activity are found in some cells of lymphoid origin. In particular, the mouse thymoma cell line W7 has about 10 times higher binding activity than other cell lines. The oligonucleotide is bound with a single high affinity constant, as shown by Scatchard plot analyses. Cell extracts fractionated by centrifugation on glycerol gradients show a single peak of binding activity, which co-sediments with (2'-5')oligo(A)-dependent endoribonuclease (RNase L). This enzyme apparently binds the oligonucleotide, as shown by experiments with an analog of (2'-5')oligo(A) which competes in the binding and inhibits the RNase L. This endonuclease cannot be directly assayed in unfractionated cell or tissue extracts with high levels of other nuclease activities. The binding assay for the oligonucleotide may provide an estimate of RNase L levels in such cell and tissue extracts.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7287731

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Monoclonal antibodies to 5'-triphospho-(2'-5')adenyladenosine oligonucleotides.

Authors:  H Cailla; C Le Borgne De Kaouel; D Roux; M Delaage; J Marti
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

2.  (2'-5')Oligoadenylate in rat liver: modulation after partial hepatectomy.

Authors:  M Etienne-Smekens; P Vandenbussche; J Content; J E Dumont
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

3.  Immunological evidence for the in vivo occurrence of (2'-5')adenylyladenosine oligonucleotides in eukaryotes and prokaryotes.

Authors:  L Laurence; J Marti; D Roux; H Cailla
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

4.  Induction of ppp(A2'p)nA-dependent RNase in murine JLS-V9R cells during growth inhibition.

Authors:  H Jacobsen; D Krause; R M Friedman; R H Silverman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

5.  Activation of NF-kappaB by double-stranded RNA (dsRNA) in the absence of protein kinase R and RNase L demonstrates the existence of two separate dsRNA-triggered antiviral programs.

Authors:  M S Iordanov; J Wong; J C Bell; B E Magun
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

6.  ICP0 prevents RNase L-independent rRNA cleavage in herpes simplex virus type 1-infected cells.

Authors:  Paul T Sobol; Karen L Mossman
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

7.  Cleavage of nascent reovirus mRNA by localized activation of the 2'-5'-oligoadenylate-dependent endoribonuclease.

Authors:  C Baglioni; A De Benedetti; G J Williams
Journal:  J Virol       Date:  1984-12       Impact factor: 5.103

8.  2',5'-Oligoadenylate synthetase levels in patients with multiple myeloma receiving maintenance therapy with interferon alpha 2b do not correlate with clinical response.

Authors:  B C Millar; J B Bell
Journal:  Br J Cancer       Date:  1995-12       Impact factor: 7.640

Review 9.  The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation.

Authors:  M R Player; P F Torrence
Journal:  Pharmacol Ther       Date:  1998-05       Impact factor: 12.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.